Publication
Insurance regulation in Asia Pacific
Ten things to know about insurance regulation in 19 countries.
United States | Publication | abril 2021
In response to FAQs on March 10 and then on March 26, Cal/OSHA clarified an employer's obligation to provide compensation to asymptomatic employees excluded from work because of their exposure to a COVID-19 case at work. Section 3205(c)(10)(C) of the Emergency Temporary COVID-19 Standard states that, for excluded employees, "employers shall continue and maintain an employee's earnings, seniority, and all other employee rights and benefits, including the employee's right to their former job status, as if the employee had not been removed from their job." Excluded employees who do not contract COVID-19 and do not develop any symptoms must be excluded from the workplace for up to 10 days. Among other things, the new guidance from Cal/OSHA makes clear that exclusion pay is not required when the employee's own COVID-19 symptoms prevent her from working (though the employee may be eligible for the new COVID-19 supplemental paid sick leave). And, employers may require employees to use COVID-19 supplemental paid sick leave pay in lieu of providing exclusion pay.
Publication
Ten things to know about insurance regulation in 19 countries.
Publication
In King Crude Carriers SA & Ors v Ridgebury November LLC & Ors [2024] EWCA Civ 719 the Court of Appeal held that the claimant sellers (the Sellers) were entitled to claim the deposits promised under sale contracts as a debt despite the defendant buyers’ (the Buyers) breach of contract, which had resulted in the non-fulfilment of a condition precedent to the payment of the deposits.
Publication
As previously observed, conflicts occasionally arise between mortgagees and charterers where a mortgagee wishes to take prompt action to enforce its rights, but the charterer wishes such enforcement action to be deferred until the end of the charter.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025